| In Their Own Words
Members of the first Vioxx jury discuss their decision to hold
Merck liable.
"We expect accountability, we expect
them to be open with us, we expect them to be honest with us."
Marsha Robbins, the forewoman, "after a jury found the
maker of Vioxx had acted recklessly in selling it despite knowledge
of its risks."[The New York Times, 8/20/05]
On sending a message to Merck and the drug industry:
- "Stop doing the minimum to put a drug on the market",
juror Derrick Chizer said. "Go out there and do your very
best. ... Merck makes a lot of medicines. They're staking our
lives. Be responsible."
[The Dallas Morning News, 8/20/05]
- "Juror Derrick Chizer, who voted for Ernst, said the majority
of jurors believed a heart attack triggered the Texas man's fatal
arrhythmia, or irregular heartbeat. 'It could have been prevented,'
he said. 'That is the message (to pharmaceutical companies). Respect
us."
[The Associated Press, 8/20/05]
- "[Juror Derrick] Chizer said the message jurors wanted
to send to Merck was for the company to take their responsibility
seriously. 'Every life counts to us. They should be responsible.
If they care, then show it,' said Chizer, 43, of Pearland, who
works for the Social Security Administration.
[The Houston Chronicle, 8/20/05]
- Juror Lorraine Blas: "We wanted to make a statement. We
wanted to let all the companies know that they can't do this.
It's not right. You can't hide information. You have to give all
the information."
[The Early Show, CBS News Transcripts, 8/20/05]
- "They needed to be held accountable for putting a drug
out there that shouldn't be out there", said Stacy Smith,
a 21-year-old child care provider who stood with the majority
in the 10-2 vote in favor of the man's widow, Carol Ernst. "I
want them to listen", said Marsha Robbins, a 53-year-old
homemaker who was the presiding juror and the oldest of the panel.
... David Webb, a 20-year-old electrician and one of the two youngest
jurors on the panel, said he went into deliberations supporting
Ernst, "but I wanted to give the defendants a chance. We
just really didn't find anything that helped them."
[Associated Press, 8/19/05]
On Merck's decision to market Vioxx despite knowing the
problems with the drug:
- "One of the jurors, 21-year-old Stacy Smith, said she was
shocked at evidence that showed the company knew the dangers of
Vioxx long before it withdrew the drug. 'They knew, and they still
put it out anyway", she said."
[Sunday Express (U.K.), 8/21/05]
- "Several jurors said that company documents showed Merck
seemed to care more about profits from the drug than the public's
welfare. Stacy Smith, 21, said she was swayed by documents written
by Merck executives. 'They knew,' she said, 'and they still put
[Vioxx] out.' ...Juror Lorraine Blas, 41, said she reviewed several
documents in the jury room and found a particularly damaging Merck
e-mail on cardiovascular events and testing dating back years.
'I felt Merck knew something was going on as early as 1997,' she
said. Juror Derrick Chizer, a Social Security service representative,
said he was irritated that Merck failed to send any executives
who were responsible for bringing Vioxx to market to the trial.
'Not one bigwig from Merck came down. Not one of them took the
time,' Chizer said. 'One death in my life would make a difference.
Why wouldn't it make a difference to them?"
[Los Angeles Times, 8/20/05]
- Juror Lorraine Blas: "The evidence there - after reviewing
all the evidence in the jury room, I decided from looking at the
paperwork they knew the problems this medication was causing and
they hid it from us. Rather than telling us the good and the bad,
they only told us the good."
[The Early Show, CBS News Transcripts, 8/20/05]
- "Merck did not let us know the full problems of the drug",
juror Rhonda Wade said. "I was shocked."
[The Dallas Morning News, 8/20/05]
- "'This case certainly opened my eyes,' said juror Rhonda
Wade, a 41-year-old mother of four from nearby Clute, Texas. 'They
ignored an FDA warning letter about their marketing and they didn't
give [regulators] all of the information.' 'I will probably never
take another pill without totally investigating it, questioning
my doctor and pharmacists and reading all the information I can,'
Wade said." [Chicago Tribune, 8/20/05]
- Juror Stacy Smith: "The issue, to me, was, did Merck know
before they put the drug on the market, and when they did, why
didn't they do something about it immediately?"
[World News Tonight, ABC News Transcripts, 8/19/05]
- "Look at the evidence,' said Marsha Robbins, the forewoman,
when asked whether the award was excessive. 'They knew they had
a problem,'' she said of Merck, the maker of Vioxx. ...One factor
that swayed the jury, Ms. Blas said, was another look at Merck's
labeling of Vioxx, even after the company began warning doctors
that the drug could be linked to 'cardiovascular events' like
heart attacks and strokes. 'In the first label, it didn't jump
out at you that C.V. events were happening,' Ms. Blas said, referring
to a cardio vascular event. 'You had to dig three levels to see
it."
[The New York Times, 8/20/05]
On how the jury determined the punitive award amount:
- Juror Rhonda Wade: "Our award was based on the fact that
once they figured out they had no choice to make the [warning]
label change, they chose to stall it in order to make as much
as $229 million. And we don't want them to stall. We want them
to tell us the truth, and be responsible. ...Looking through their
evidence, and time after time, you could see where they knew about
the CV [cardiovascular] events and how important it was and they
didn't do anything about it. That's what made up my mind."
[Newsnight with Aaron Brown, CNN, 8/19/05]
- Lisa Stark, ABC News Reporter (Voice Over): "The case against
Merck relied heavily on internal company documents including ones
that seemed to show Merck knew about possible heart risks, even
before Vioxx went on the market. Jurors were also told Merck delayed
strengthening Vioxx's warning label. And that's how they decided
on the amount of punitive damages." Juror David Webb: "$229
million was the amount of money that Merck would gain if they
put off changing the label."
[Good Morning America, ABC News Transcripts, 8/20/05]
- "Carol Ernst was awarded $ 253.45 million Friday, including
$ 229 million in punitive damages. 'That was a number they kept
saying over and over,' juror Stacy Smith, a 21-year-old college
student, said. 'It was in our mind. When you're sitting there
for five weeks and that number kept being repeated, the number
stuck in our mind."
[Houston Chronicle, 8/20/05]
- "Because of caps under state law, Hardin will have to reduce
the amount of the punitive damages to $ 1.65 million, making the
total $ 26.1 million. Juror Rhonda Wade, 41, of Clute, said those
on the seven-man, five-woman jury were not aware of a cap on punitive
damages. 'We assumed that no matter what the number, it would
be cut back,' she said. 'We wanted to get the message across."
[The Houston Chronicle, 8/20/05]
- In interviews after the decision, jurors said they had made
the large punitive award to send a message that drug makers must
disclose the risks of their medicines. "Respect us, that's
the message", said Derrick Chizer, a juror. "Respect
us."
[The New York Times, 8/20/05]
- "When you write that figure ($ 229 million), it means Merck
is going to have to get responsible", said Rhonda Wade, 41,
of Clute. "It's not the money", added Marsha Robbins,
53, of Freeport, who served as the presiding juror. "It's
accountability."
[The Houston Chronicle, 8/20/05]
If you or a loved one is in need of legal assistance, call Adel
& Pollack at (310) 443-4455 or submit
an online questionnaire. The initial consultation is free of
charge, and if we agree to handle your case, in most cases we will
work on a contingency fee basis, which means we get paid for our
services only if there is a monetary recovery of funds. In many
cases, a lawsuit must be filed before an applicable expiration date,
known as a statute of limitations. Please call right away to ensure
that you do not waive your right to possible compensation.
|